Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) announced that partner Hansoh Pharmaceutical Group Company Limited reported positive results from a Phase 3 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE